
Priomed Life Sciences Private Limited
About Priomed Life Sciences Private Limited
Data last updated:
Priomed Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 06 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2015PTC098727. Its GSTIN is 33AAHCP9475E1Z6 (Tamil Nadu).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Ansar Basha Mansoor Basha and Ganapathy Girirajan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.3 First Floor 11th Street Surendra Nagar Adambakkam, Chennai, Tamil Nadu, India – 600088.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.39 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹7.05 Lakh (net margin 5.1%) and EBITDA of ₹11.04 Lakh (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Priomed Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo.3 First Floor 11th Street Surendra Nagar Adambakkam, Chennai, Tamil Nadu, India – 600088
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Priomed Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Priomed Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Priomed Life Sciences Private Limited, buy the company report.
Financials of Priomed Life Sciences Private Limited
FY 2025 filings availablePriomed Life Sciences Private Limited reported revenue of ₹1.39 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 8% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Priomed Life Sciences Private Limited, buy the company report.
Board of directors of Priomed Life Sciences Private Limited
Priomed Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ansar Basha Mansoor Basha | Director | 06 Jan 2015 | 11 Years 10 Months | Current |
| Ganapathy Girirajan | Director | 06 Jan 2015 | 11 Years 10 Months | Current |
| Abdulhameed Kather Ismail | Director | 27 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Priomed Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orbit Ace Medicare Private Limited | ₹1.4 Cr (FY 2024) | -35.0% | Chennai, Tamil Nadu, India | |||
| Alixar Healthcare Private Limited | ₹1.39 Cr (FY 2024) | 37.0% | Bhopal, Madhya Pradesh, India | |||
| Eonbt Private Limited | ₹1.39 Cr (FY 2025) | 1076.0% | Noida, Uttar Pradesh, India | |||
| Priomed Life Sciences Private Limitedthis company | ₹1.39 Cr (FY 2025) | ₹7.05 Lakh | 5.1% | 8.0% | Chennai, Tamil Nadu, India | |
| Careway Exim Private Limited | ₹1.38 Cr (FY 2017) | 53.0% | Nellore, Andhra Pradesh, India | |||
| Vernal Healthcare Private Limited | ₹1.38 Cr (FY 2024) | 389.0% | Kochi, Kerala, India |
To see the full peer comparison of Priomed Life Sciences Private Limited, buy the company report.
Auditor
Priomed Life Sciences Private Limited is audited by K.Viswanathan & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.Viswanathan & Co | FY 2017 | 202402 |
Shareholding
The shareholding of Priomed Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Priomed Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Priomed Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Priomed Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Priomed Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCP9475E1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Priomed Life Sciences Private Limited, buy the company report.
Recent activity
Priomed Life Sciences Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Perumal Vijayakumar ceased to be Director on 31 Jan 2018.
Frequently asked questions
Priomed Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 06 January 2015 (11+ years old) and is registered under CIN U74900TN2015PTC098727.
Priomed Life Sciences has 3 current directors:
- Ansar Basha Mansoor Basha - Director
- Ganapathy Girirajan - Director
- Abdulhameed Kather Ismail - Director
The latest financial statements of Priomed Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Priomed Life Sciences is 33AAHCP9475E1Z6, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Priomed Life Sciences is U74900TN2015PTC098727. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Priomed Life Sciences was incorporated on 06 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Priomed Life Sciences by revenue are Orbit Ace Medicare Private Limited, Alixar Healthcare Private Limited, Eonbt Private Limited, Careway Exim Private Limited, Vernal Healthcare Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Perumal Vijayakumar ceased to be Director on 31 Jan 2018. Abdulhameed Kather Ismail was appointed as Director on 27 Sep 2016. Perumalsamy Ramadas ceased to be Director on 16 Mar 2016. Priomed Life Sciences has 7 board changes on record in total.
The registered office of Priomed Life Sciences is at No.3 First Floor 11th Street Surendra Nagar Adambakkam, Chennai, Tamil Nadu, India – 600088.
Priomed Life Sciences operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Priomed Life Sciences is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.

